Clinical Trials Browser

Phase 3 × OTHER × daratumumab × Clear all

NCT05675319 2026-01-05

AlloRelapseMM

Phase 3 Terminated

Multiple Myeloma

NCT06867991 2025-07-15

RADIA

Phase 3 Recruiting

Autoimmune Diseases of the Nervous System, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT03836014 2024-12-06

CONFIRM

Phase 3 Active not recruiting

Multiple Myeloma, Recurrence

NCT06187441 2024-08-19

HOVON174MM

Phase 3 Recruiting

Multiple Myeloma